These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 8243108

  • 1. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR, Gregory CM.
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [Abstract] [Full Text] [Related]

  • 2. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
    Pranzatelli MR, Murthy JN, Pluchino RS.
    J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361
    [Abstract] [Full Text] [Related]

  • 3. Neonatal 5,7-DHT lesions upregulate [3H]mesulergine-labelled spinal 5-HT1C binding sites in the rat.
    Pranzatelli MR.
    Brain Res Bull; 1990 Jul; 25(1):151-3. PubMed ID: 2207701
    [Abstract] [Full Text] [Related]

  • 4. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA, Davis KH, Titeler M.
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [Abstract] [Full Text] [Related]

  • 5. (R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.
    Peroutka SJ, Hamik A, Harrington MA, Hoffman AJ, Mathis CA, Pierce PA, Wang SS.
    Mol Pharmacol; 1988 Oct; 34(4):537-42. PubMed ID: 3173334
    [Abstract] [Full Text] [Related]

  • 6. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D, Engel G, Kalkman HO.
    Eur J Pharmacol; 1985 Nov 26; 118(1-2):13-23. PubMed ID: 2935410
    [Abstract] [Full Text] [Related]

  • 7. p,p'-DDT myoclonic/epileptic model: serotonin receptor binding and behavioral studies in the rat.
    Pranzatelli MR, Tailor PT, Pluchino R, Gonzales W, Simmens S.
    Neurotoxicology; 1994 Nov 26; 15(2):261-72. PubMed ID: 7991214
    [Abstract] [Full Text] [Related]

  • 8. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.
    Hoyer D, Pazos A, Probst A, Palacios JM.
    Brain Res; 1986 Jun 18; 376(1):97-107. PubMed ID: 2941113
    [Abstract] [Full Text] [Related]

  • 9. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
    Stratford CA, Tan GL, Hamblin MW, Ciaranello RD.
    Mol Pharmacol; 1988 Oct 18; 34(4):527-36. PubMed ID: 3139989
    [Abstract] [Full Text] [Related]

  • 10. Changes in the rat brain 5-HT1A and 5-HT2 receptors after chronic administration of levoprotiline, (+)-oxaprotiline and other antidepressant drugs.
    Klimek V, Zak-Knapik J, Cannizzaro C.
    Pol J Pharmacol Pharm; 1992 Oct 18; 44(6):549-60. PubMed ID: 1305956
    [Abstract] [Full Text] [Related]

  • 11. Effects of serotonergic denervation on the density and plasticity of brain muscarinic receptors in the rat.
    Alonso R, Soubrie P.
    Synapse; 1991 May 18; 8(1):30-7. PubMed ID: 1714634
    [Abstract] [Full Text] [Related]

  • 12. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons.
    Sheldon PW, Aghajanian GK.
    Synapse; 1991 Nov 18; 9(3):208-18. PubMed ID: 1776132
    [Abstract] [Full Text] [Related]

  • 13. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM, Mitchell WM, Garlick RK, Glennon RA, Teitler M, De Souza EB.
    J Pharmacol Exp Ther; 1990 Nov 18; 255(2):843-57. PubMed ID: 2243353
    [Abstract] [Full Text] [Related]

  • 14. Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.
    Choudhary MS, Craigo S, Roth BL.
    Mol Pharmacol; 1992 Oct 18; 42(4):627-33. PubMed ID: 1435740
    [Abstract] [Full Text] [Related]

  • 15. Regional central serotonin-2 receptor binding and phosphoinositide turnover in rats with 5,7-dihydroxytryptamine lesions.
    Butler PD, Pranzatelli MR, Barkai AI.
    Brain Res Bull; 1990 Jan 18; 24(1):125-9. PubMed ID: 2155684
    [Abstract] [Full Text] [Related]

  • 16. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
    Branchek T, Adham N, Macchi M, Kao HT, Hartig PR.
    Mol Pharmacol; 1990 Nov 18; 38(5):604-9. PubMed ID: 2233697
    [Abstract] [Full Text] [Related]

  • 17. Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study.
    Hrdina PD, Vu TB.
    Synapse; 1993 Aug 18; 14(4):324-31. PubMed ID: 8248854
    [Abstract] [Full Text] [Related]

  • 18. Modulation of brainstem 5-HT1C receptors by serotonergic drugs in the rat.
    Pranzatelli MR, Tailor PT.
    Gen Pharmacol; 1994 Oct 18; 25(6):1279-84. PubMed ID: 7875557
    [Abstract] [Full Text] [Related]

  • 19. Antidepressant-induced increase in high-affinity rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic function.
    Zhao Y, Zhang HT, O'Donnell JM.
    J Pharmacol Exp Ther; 2003 Oct 18; 307(1):246-53. PubMed ID: 12954819
    [Abstract] [Full Text] [Related]

  • 20. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites.
    Hoyer D, Waeber C, Pazos A, Probst A, Palacios JM.
    Neurosci Lett; 1988 Mar 10; 85(3):357-62. PubMed ID: 2966310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.